|
Market Closed -
Other stock markets
|
After hours 16:00:01 | |||
| 128.40 EUR | +3.72% |
|
127.50 | -0.70% |
| 10:17am | Gordon Haskett Adjusts Price Target on Target to $170 From $160, Maintains Buy Rating | MT |
| 07-27 | Former FDA chief says Central Mexico may have broad cyclosporiasis contamination | RE |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 46.95x | 12.18x | 3.6x | 1.38x | 29.06x | 35.76x | 0.55% | 429B | ||
| 15.87x | 3.41x | 2.27x | 0.84x | 8.34x | 11.09x | 3.12% | 48.19B | ||
| 36.83x | 27.37x | 3.91x | 6.89x | 21.51x | 26.78x | 0.25% | 36.51B | ||
| 17.08x | 2.88x | 2.24x | 0.68x | 8.75x | 12.86x | 1.89% | 27.79B | ||
| 24.18x | 3.99x | 0.93x | 1.21x | 13.04x | 16.66x | 0.94% | 16.87B | ||
| 17.36x | -40.85x | 0.15x | 1.63x | 7.9x | 13.8x | 1.43% | 6.68B | ||
| 15.64x | 0.51x | 3.03x | 0.53x | 7.88x | 16.04x | 4.56% | 4.61B | ||
| 15.33x | 2.02x | 0.98x | 1.26x | 9.02x | 10.92x | -.--% | 4.17B | ||
| 10.84x | 2.57x | 0.36x | 0.73x | 5.91x | 9.98x | 4.36% | 3.07B | ||
| 126.83x | 2.93x | -1.69x | 0.46x | 10.32x | 21.05x | 0.53% | 2.28B | ||
| 19.5x | 3.65x | -1.05x | 0.97x | 9.66x | 14.19x | -.--% | 2.22B | ||
| 15.74x | 2.41x | 1.36x | 0.7x | 7x | 8.67x | 2.11% | 1.47B | ||
| 9.9x | - | 3.27x | - | - | - | 2.97% | 54.57M | ||
| Average | 28.62x | 1.92x | 1.49x | 1.44x | 11.53x | 16.48x | 1.75% | 44.81B | |
| Weighted average by Cap. | 40.79x | 10.81x | 3.24x | 1.63x | 24.56x | 30.58x | 0.88% |
- Stock Market
- Stocks
- TGT Stock
- DYH Stock
- Sector Target Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















